Advanced search
Publication Cover
Bioanalysis Volume 1, 2009 - Issue 9
Submit an article Journal homepage
289
Views
0
CrossRef citations to date
0
Altmetric
Review

Spectroscopic and Statistical Methods in Metabonomics

Daniel S Waterman1 Metabometrix Ltd, Incubator, Prince Consort Road, London, SW7 2BP, UK;2 [email protected]Correspondence[email protected]
,
Frank W Bonner1 Metabometrix Ltd, Incubator, Prince Consort Road, London, SW7 2BP, UK
&
John C Lindon1 Metabometrix Ltd, Incubator, Prince Consort Road, London, SW7 2BP, UK
Pages 1559-1578 | Published online: 07 Dec 2009

Bibliography

  • Nicholson JK , WilsonID. High resolution proton magnetic resonance spectroscopy of biological-fluids. Prog. NMR Spectrosc. 21, 449–501 (1989).
  • Nicholson JK , LindonJC, HolmesE. ‘Metabonomics‘: understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica29, 1181–1189 (1999).
  • Nicholson JK , ConnellyJ, LindonJC, HolmesE. Metabonomics: a platform for studying drug toxicity and gene function. Nat. Rev. Drug Disc. 1, 153–162 (2002).
  • van der Greef J , TasAC, BouwmanJ, Ten Noever de Brauw MC, Schreurs WHP. Evaluation of field-desorption and fast atom-bombardment mass-spectrometric profiles by pattern-recognition techniques. Anal. Chim. Acta150, 45–52 (1983).
  • Gartland KPR , SaninsSM, NicholsonJK, SweatmanBC, BeddellCR, LindonJC. Pattern recognition analysis of high resolution 1H NMR spectra of urine. A nonlinear mapping approach to the classification of toxicological data. NMR Biomed. 3, 166–172 (1990).
  • Gartland KPR , BeddellCR, LindonJC, NicholsonJL. The application of pattern recognition methods to the analysis and classification of toxicological data derived from proton NMR spectroscopy of urine. Mol. Pharmacol. 39, 629–642 (1990).
  • Nicholson JK , WilsonID. Understanding ‘global’ systems biology: metabonomics and the continuum of metabolism. Nat. Rev. Drug Discov. 2, 668–676 (2003).
  • Nicholson JK , HolmesE, LindonJC, WilsonID. The challenges of modeling mammalian biocomplexity. Nat. Biotechnol. 22, 1268–1274 (2004).
  • Lindon JC , NicholsonJK, HolmesE. The Handbook of Metabonomics and Metabolomics. Elsevier, Amsterdam, The Netherlands (2007).
  • Lamers RJAN , WesselsECHH, van der Sandt JJMet al. A pilot study to investigate effects of inulin on Caco-2 cells through in vitro metabolic fingerprinting. J. Nutrition133, 3080–3084 (2003).
  • Villas-Boas SG , Hojer-PedersenJ, AkessonM, SmedsgaardJ, NielsenJ. Global metabolite analysis of yeast: evaluation of sample preparation methods. Yeast22, 1155–1169 (2005).
  • Bollard ME , XuJS, PurcellWet al. Metabolic profiling of the effects of d-galactosamine in liver spheroids using 1H NMR and MAS-NMR spectroscopy. Chem. Res. Toxicol. 15, 1351–1359 (2002).
  • Fiehn O . Metabolomics – the link between genotypes and phenotypes. Plant Mol. Biol. 48, 155–171 (2002).
  • Ullsten S , DanielssonR, BäckströmD, SjöbergP, BergquistJ. Urine profiling using capillary electrophoresis-mass spectrometry and multivariate data analysis. J. Chromatogr. A1117(1), 87–93 (2006).
  • Harrigan GG , LaPlanteRH, CosmaGNet al. Application of high-throughput Fourier-transform infrared spectroscopy in toxicology studies: contribution to a study on the development of an animal model for idiosyncratic toxicity. Toxicol. Lett. 146(3), 197–205 (2004).
  • Gamache PH , MeyerDF, GrangerMC, AcworthIN. Metabolomic applications of electrochemistry/mass spectrometry. J. Am. Soc. Mass Spec. 15(12), 1717–1726 (2004).
  • Liu M , NicholsonJK, LindonJC. High resolution diffusion- and relaxation-edited one- and two-dimensional 1H NMR spectroscopy of biological fluids. Anal. Chem. 68, 3370–3376 (1996).
  • Nicholson JK , FoxallPJD, SpraulM, FarrantRD, LindonJC. 750 MHz 1H and 1H-13C NMR spectroscopy of human blood plasma. Anal. Chem. 67, 793–811 (1995).
  • Lindon JC , NicholsonJK, EverettJR. NMR spectroscopy of biofluids. Annual Report NMR Spectroscopy38, 1–88 (1999).
  • Keun HC , BeckonertO, GriffinJLet al. Cryogenic probe 13C NMR spectroscopy of urine for metabonomic studies. Anal. Chem. 74, 4588–4593 (2002).
  • Price KE , VandaveerSS, LunteCE, LariveCK. Tissue targeted metabonomics: metabolic profiling by microdialysis sampling and microcoil NMR. J. Pharmaceut. Biomed. Anal. 38, 904–909 (2005).
  • Garrod SL , HumpferE, SpraulMet al. High resolution magic angle spinning 1H NMR spectroscopic studies on intact rat renal cortex and medulla. Magn. Reson. Med. 41, 1108–1118 (1999).
  • Cheng LL , ChangIW, LouisDN, GonzalezRG. Correlation of high-resolution magic angle spinning proton magnetic resonance spectroscopy with histopathology of intact human brain tumor specimens. Cancer Res. 58, 1825–1832 (1998).
  • Stein SE . An integrated method for spectrum extraction and compound identification from gas chromatography/mass spectrometry data. J. Am. Soc. Mass Spec. 10, 770–781 (1999).
  • Fiehn O . Extending the breadth of metabolite profiling by gas chromatography coupled to mass spectrometry. TrAC27, 261–269 (2008).
  • Morris M , WatkinsSM. Focused metabolomic profiling in the drug development process: advances from lipid profiling. Curr. Opin. Chem. Biol. 9, 407–412 (2005).
  • Wilson ID , PlumbR, GrangerJ, MajorH, WilliamsR, LenzEM. HPLC–MS-based methods for the study of metabonomics. J. Chromatog. B817, 67–76 (2005).
  • Payne TG , SouthamAD, ArvanitisTN, ViantMR. A signal filtering method for improved quantification and noise discrimination in Fourier transform ion cyclotron resonance mass spectrometry-based metabolomics data. J. Am. Soc. Mass Spec. 20, 1087–1095 (2009).
  • Gika HG , TheodoridisGA, WilsonID. Liquid chromatography and ultra-performance liquid chromatography–mass spectrometry fingerprinting of human urine: sample stability under different handling and storage conditions for metabonomics studies. J Chromatog. A1189, 314–322 (2008).
  • Soga T , OhashiY, UenoY, NasaokaH, TomitaM, NishiokaT. Quantitative metabolome analysis using capillary electrophoresis mass spectrometry. J. Proteome Res. 2, 488–494 (2003).
  • Lindon JC , NicholsonJK, WilsonID. Directly-coupled HPLC–NMR and HPLC–NMR–MS in pharmaceutical research and development. J. Chromatogr. B748, 233–258 (2000).
  • Antti H , EbbelsTMD, KeunHCet al. Statistical experimental design and partial least squares regression analysis of biofluid metabonomic NMR and clinical chemistry data for screening of adverse drug effects. Chemometr. Intel. Lab. 73, 139–149 (2004).
  • Jonsson P , JohanssonAI, GullbergJet al. High-throughput data analysis for detecting and identifying differences between samples in GC/MS-based metabolomic analyses. Anal. Chem. 77, 5635–5642 (2005).
  • Idborg-Bjorkman H , Edlund P-O, Kvalheim OM, Schuppe-Koistinen I, Jacobsson SP. Screening of biomarkers in rat urine using LC/electrospray ionization-MS and two-way data analysis. Anal Chem. 75, 4784–4792 (2003).
  • Farrant RD , LindonJC, RahrE, SweatmanBC. An automatic data reduction and transfer method to aid pattern-recognition analysis and classification of NMR spectraJ. Pharmaceut. Biomed. 10, 141–144 (1992).
  • Holmes E , FoxallPJ, NicholsonJKet al. Automatic data reduction and pattern-recognition methods for analysis of H-1 nuclear magnetic resonance spectra of human urine from normal and pathological states. Anal. Biochem. 220, 284–296 (1994).
  • Stoyanova R , NichollsAW, NicholsonJK, LindonJC, BrownTR. Automatic alignment of individual peaks in large high-resolution spectral data sets. J. Magn. Reson. 170, 329–235 (2004).
  • Yang J , XuG, ZhengYet al. Strategy for metabonomics research based on high-performance liquid chromatography and liquid chromatography coupled with tandem mass spectrometry. J. Chromatog. A1084, 214–221 (2005).
  • Jonsson P , BruceSJ, MoritzT, TryggJet al. Extraction, interpretation and validation of information for comparing samples in metabolic LC/MS data sets. Analyst130, 701–707 (2005).
  • Veselkov KA , LindonJC, EbbelsTMDet al. Recursive segment-wise peak alignment of biological 1H NMR spectra for improved metabolic biomarker recovery. Anal. Chem. 81, 56–66 (2009).
  • Lindon JC , HolmesE, NicholsonJ. Pattern recognition methods and applications in biomedical magnetic resonance. Prog. NMR Spectrosc. 39, 1–40 (2001).
  • Trygg J , WoldS. Orthogonal projections to latent structures (O-PLS)J. Chemomet. 16, 119–128 (2002).
  • Holmes E , NicholsonJK, TranterG. Metabonomic characterization of genetic variations in toxicological and metabolic responses using probabilistic neural networks. Chem. Res. Toxicol. 14, 182–191 (2001).
  • Kell DB . Metabolomics and machine learning: explanatory analysis of complex metabolome data using genetic programming to produce simple, robust rules. Mol. Biol. Rep. 29, 237–241 (2002).
  • Kell DB . Metabolomics, modelling and machine learning in systems biology – towards an understanding of the languages of cells. FEBS J. 273, 873–894 (2006).
  • Vehtari A , Makinen V-P, Soininen Pet al. A novel Bayesian approach to quantify clinical variables and to determine their spectroscopic counterparts in 1H NMR metabonomic data. BMC Bioinformatics8(Suppl. 2), S8 (2007).
  • Mahadevan S , ShahSL, MarrieTJ, SlupskyCM. Analysis of metabolomic data using support vector machines. Anal. Chem. 80, 7562–7570 (2008).
  • Cloarec O , DumasME, CraigAet al. Statistical total correlation spectroscopy: an exploratory approach for latent biomarker identification from metabolic 1H NMR data sets. Anal. Chem. 77, 1282–1289 (2005).
  • Holmes E , CloarecO, NicholsonJK. Probing latent biomarker signatures and in vivo pathway activity in experimental disease states via statistical total correlation spectroscopy (STOCSY) of biofluids: application to HgCl2 toxicity. J. Proteome Res. 5, 1313–1320 (2006).
  • Coen M , Hong Y-S, Cloarec Oet al. Heteronuclear 1H-31P statistical total correlation NMR spectroscopy of intact liver for metabolic biomarker assignment: application to galactosamine-induced hepatotoxicity. Anal. Chem. 79(23), 8956–8966 (2007).
  • Cloarec O , CampbellA, Tseng L-Het al. Virtual chromatographic resolution enhancement in cryoflow LC–NMR experiments via statistical total correlation spectroscopy. Anal. Chem. 79, 3304–3311 (2007).
  • Crockford DJ , HolmesE, LindonJCet al. Statistical heterospectroscopy (SHY), a new approach to the integrated analysis of NMR and UPLC-MS datasets: application in metabonomic toxicology studies. Anal. Chem. 78, 363–371 (2006).
  • Crockford DJ , LindonJC, CloarecOet al. Statistical search space reduction and 2-dimensional data display approaches for UPLC–MS in biomarker discovery and pathway analysis. Anal. Chem. 78, 4398–4408 (2006).
  • Bollard ME , StanleyEG, LindonJC, NicholsonJK, HolmesE. NMR-based metabonomics approaches for evaluating physiological influences on biofluid composition. NMR Biomed. 18, 143–162 (2005).
  • Dumas M-E , MaibaumEC, TeagueCet al. Assessment of analytical reproducibility of 1H NMR spectroscopy based metabonomics for large-scale epidemiological research: the INTERMAP study. Anal. Chem. 78, 2199–2208 (2006).
  • Lenz EM , BrightJ, WilsonIDet al. Metabonomics, dietary influences and cultural differences: a 1H NMR-based study of urine samples obtained from healthy British and Swedish subjects. J. Pharmaceut. Biomed. Anal. 36, 841–849 (2004).
  • Lenz EM , BrightJ, WilsonID, MorganSR, NashAFP. A 1H NMR-based metabonomic study of urine and plasma samples obtained from healthy human subjects. J. Pharmaceut. Biomed. Anal. 33, 1103–1115 (2003).
  • Holmes E , LooRL, StamlerJet al. Human metabolic phenotype diversity and its association with diet and blood pressure. Nature453, 396–400 (2008).
  • Nicholls AW , Mortishire-SmithRJ, NicholsonJK. NMR spectroscopic-based metabonomic studies of urinary metabolite variation in acclimatizing germ-free rats. Chem. Res. Toxicol. 16, 1395–1404 (2003).
  • Robosky LC , WellsDF, EgnashLA, ManningML, ReilyMD, RobertsonDG. Metabonomic identification of two distinct phenotypes in Sprague-Dawley (Crl:CD(SD)) rats. Toxicol. Sci. 87, 277–284 (2005).
  • Wang Y , HolmesE, NicholsonJKet al. Metabonomic investigations in mice infected with Schistosoma mansoni: an approach for biomarker identification. Proc. Natl Acad. Sci. USA101, 12676–12681 (2004).
  • Martin FPJ , WangY, SprengerNet al. Effects of probiotic Lactobacillus paracasei treatment on the host gut tissue metabolic profiles probed via magic-angle-spinning NMR spectroscopy. J. Proteome Res. 4, 1471–1481 (2007).
  • Solanky KS , BaileyNJ, Beckwith-HallBMet al. Biofluid 1H NMR-based metabonomic techniques in nutrition research – metabolic effects of dietary isoflavones in humans. J. Nutrit. Biochem. 16, 236–244 (2005).
  • Wang Y , TangH, NicholsonJK, HylandsPJ, SampsonJ, HolmesE. A metabonomic strategy for the detection of the metabolic effects of chamomile (Matricaria recutita L.) ingestion. J. Agricul. Food Chem. 53, 191–196 (2005).
  • Martin FJ , WangY, SprengerNet al. Probiotic modulation of symbiotic gut microbial-host metabolic interactions in a humanized microbiome mouse model. Mol. Syst. Biol. 4, 157 (2008).
  • Lindon JC , HolmesE, BollardME, StanleyEG, NicholsonJK. Metabonomics technologies and their applications in physiological monitoring, drug safety evaluation and disease diagnosis. Biomarkers9, 1–31 (2004).
  • Lindon JC , HolmesE, NicholsonJK. Toxicological applications of magnetic resonance. Prog. NMR Spectrosc. 45, 109–143 (2004).
  • Lindon JC , NicholsonJK, HolmesEet al. Contemporary issues in toxicology – the role of metabonomics in toxicology and its evaluation by the COMET project. Toxicol. Appl. Pharmacol. 187, 137–146 (2003).
  • Keun HC , EbbelsTMD, BollardMEet al. Geometric trajectory analysis of metabolic responses to toxicity can define treatment specific profiles. Chem. Res. Toxicol. 17, 579–587 (2004).
  • Ebbels T , KeunH, BeckonertOet al. Toxicity classification from metabonomic data using a density superposition approach: ‘CLOUDS‘. Anal. Chim. Acta490, 109–122 (2003).
  • Sweatman BC , FarrantRD, HolmesE, GhauriFY, NicholsonJK, LindonJC. 600 MHz 1H-NMR spectroscopy of human cerebrospinal fluid: effects of sample manipulation and assignment of resonances. J. Pharmaceut. Biomed. Anal. 11, 651–664 (1993).
  • Lynch MJ , MastersJ, PryorJPet al. Ultra high field NMR spectroscopic studies on human seminal fluid, seminal vesicle and prostatic secretions. J. Pharmaceut. Biomed. Anal. 12, 5–19 (1994).
  • Maher AD , PatkiP, LindonJCet al. Seminal oligouridinosis: low uridine secretion as a biomarker for infertility in spinal neurotrauma. Clin. Chem. 54, 2063–2066 (2008).
  • Brindle JT , NicholsonJK, SchofieldPM, GraingerDJ, HolmesE. Application of chemometrics to 1H NMR spectroscopic data to investigate a relationship between human serum metabolic profiles and hypertension, Analyst128, 32–36 (2003).
  • Odunsi K , WollmanRM, AmbrosoneCBet al. Detection of epithelial ovarian cancer using 1H-NMR-based metabonomics. Int. J. Cancer113, 782–788 (2005).
  • Bailey NJ , WangY, SampsonJet al. Prediction of anti-plasmodial activity of Artemisia annua extracts: application of 1H NMR spectroscopy and chemometrics. J. Pharmaceut. Biomed. Anal. 35, 117–126 (2004).
  • Albert K , MicheleS, GüntherU, FialM, GallH, SaalJ. 13C NMR investigation of synovial fluids. Mag. Res. Med. 30, 236–240 (1993).
  • Lamers RAN , DeGrootJ, Spies-FaberEJet al. Identification of disease- and nutrient-related metabolic fingerprints in osteoarthritic guinea pigs. J. Nutr. 133, 1776–1780 (2003).
  • Knubovets TL , LundinaTA, SibeldinaLA, SedovKR. 1H NMR urinalysis in glomerulonephritis: a new prognostic criterion. Magn. Reson. Imaging10, 127–134 (1992).
  • Foxall PJD , MellotteGJ, BendingMR, LindonJC, NicholsonJK. NMR spectroscopy as a novel approach to the monitoring of renal transplant function. Kidney Int. 43, 234–245 (1993).
  • Li JV , HolmesE, SaricJet al. Metabolic profiling of a Schistosoma mansoni infection in mouse tissues using magic angle spinning-nuclear magnetic resonance spectroscopy. Int. J. Parasitol. 39, 547–558 (2009).
  • Foxall PJ , PriceRG, JonesJK, NeildGH, ThompsonFD, NicholsonJK. High resolution proton magnetic resonance spectroscopy of cyst fluids from patients with polycystic kidney disease. Biochim. Biophys. Acta1138(4), 305–314 (1992).
  • Nelson TR , GilliesRJ, PowellDA, SchraderMC, ManchestersDK, PretoriusDH. High resolution proton NMR spectroscopy of human amniotic fluid, Prenatal Diagnosis7, 363–372 (1987).
  • Graça G , DuarteIF, GoodfellowBJet al. Potential of NMR spectroscopy for the study of human amniotic fluid. Anal. Chem. 79, 8367–8375 (2007).
  • Jacobs DM , DeltimpleN, van VelzenEet al. 1H NMR metabolite profiling of feces as a tool to assess the impact of nutrition on the human microbiome. NMR Biomed. 21, 615–626 (2008).
  • Tarnawski R , TarnawskiR, GrobelnyJ. Changes in elastin in human atherosclerotic aorta: carbon-13 magic angle sample-spinning NMR studies. Atherosclerosis115, 27–33 (1995).
  • Sitter B , BathenTF, TessemM, GribbestadIS. High-resolution magic angle spinning (HR MAS) MR spectroscopy in metabolic characterization of human cancer, Prog. Nuc. Mag. Res. Spec. 54, 239–254 (2009).
  • Griffin J , WilliamsH, SangE, NicholsonJK. Abnormal lipid profile of dystrophic cardiac tissue as demonstrated by one- and two-dimensional magic-angle spinning 1H NMR spectroscopy. Magn. Reson. Med. 46, 249–255 (2001).
  • Jones GL , SangE, GoddardCet al. A functional analysis of mouse models of cardiac disease through metabolic profiling. J. Biol. Chem. 280, 7530–7539 (2005).
  • Griffin JL , CemalCK, PookMA. Defining a metabolic phenotype in the brain of a transgenic mouse model of spinocerebellar ataxia 3. Physiol. Genomics16, 334–340 (2004).
  • Duarte IF , StanleyEG, HolmesEet al. Metabolic assessment of human liver transplants from biopsy samples at the donor and recipient stages using high-resolution magic angle spinning 1H NMR spectroscopy. Anal. Chem. 77, 5570–5578 (2005).
  • Nicholls AW , Mortishire-SmithRJ, NicholsonJK. NMR spectroscopic-based metabonomic studies of urinary metabolite variation in acclimatizing germ-free rats. Chem. Res. Toxicol. 16, 1395–1404 (2003).
  • Martin FJ , WangY, SprengerNet al. Probiotic modulation of symbiotic gut microbial-host metabolic interactions in a humanized microbiome mouse model. Mol. Syst. Biol. 4, 157 (2008).
  • Clayton AT , LindonJC, CloarecOet al. Pharmaco-metabonomic phenotyping and personalized drug treatment. Nature440, 1073–1077 (2006).
  • Clayton TA , BakerD, LindonJC, EverettJR, NicholsonJK. Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism. Proc. Natl Acad. Sci. USA106, 14728–14733 (2009).
  • Sansone SA , FanT, GoodacreRet al. The Metabolomics Standards Initiative. Nat. Biotech25, 846–848 (2007).
  • Jenkins H , HardyN, BeckmannMet al. A proposed framework for the description of plant metabolomics experiments and their results. Nat. Biotechnol. 22(12), 1601–1606 (2004).
  • Wishart DS , TzurD, KnoxCet al. HMDB: the Human Metabolome Database. Nucl. Acid. Res. 35, D521–D526 (2007).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.